BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359 AND Diagnosis
120 results:

  • 1. Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.
    Matthies L; Amir-Kabirian H; Gebrekidan MT; Braeuer AS; Speth US; Smeets R; Hagel C; Gosau M; Knipfer C; Friedrich RE
    PLoS One; 2024; 19(4):e0302017. PubMed ID: 38603731
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cutaneous toxicities of mitogen-activated protein kinase inhibitors in children and young adults with neurofibromatosis-1.
    Peacock BC; Tripathy S; Hanania HL; Wang HY; Sadighi Z; Patel AB
    J Neurooncol; 2024 May; 167(3):515-522. PubMed ID: 38443692
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey.
    Wolters PL; Ghriwati NA; Baker M; Martin S; Berg D; Erickson G; Franklin B; Merker VL; Oberlander B; Reeve S; Rohl C; Rosser T; Vranceanu AM
    Clin Trials; 2024 Feb; 21(1):73-84. PubMed ID: 37962219
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Multidisciplinary neurofibromatosis conference in the management of patients with neurofibromatosis type 1 and schwannomatosis in a single tertiary care institution.
    Debs P; Belzberg A; Blakeley J; Fayad L; Langmead S; Little E; Romo C; Schatz K; Slobogean B; Ahlawat S
    Skeletal Radiol; 2024 May; 53(5):909-916. PubMed ID: 37950060
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Neurofibromatosis type 1 mosaicism in patients with constitutional mismatch repair deficiency.
    Guerrini-Rousseau L; Pasmant E; Muleris M; Abbou S; Adam-De-Beaumais T; Brugieres L; Cabaret O; Colas C; Cotteret S; Decq P; Dufour C; Guillerm E; Rouleau E; Varlet P; Zili S; Vidaud D; Grill J
    J Med Genet; 2024 Jan; 61(2):158-162. PubMed ID: 37775264
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
    Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
    Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy.
    Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
    JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tumor Androgen Receptor Protein Level Is Positively Associated with a Better Overall Survival in Melanoma Patients.
    Singh N; Khatib J; Chiu CY; Lin J; Patel TS; Liu-Smith F
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833272
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Lymphomas in patients with neurofibromatosis type 1 (nf1): another malignancy in the nf1 syndrome?
    Fareez F; Wang BH; Brain I; Lu JQ
    Pathology; 2023 Apr; 55(3):302-314. PubMed ID: 36774237
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MULTIPLE NEUROENDOCRINE NEOPLASIA IN A PATIENT WITH TYPE I NEUROFIBROMATOSIS (nf1): REPORT OF A NEW MUTATION (nf1, EXONS 2-30 DELETION) AND LITERATURE REVIEW.
    Kanno DT; Mattos RLM; Campos FG; Siqueira RM; Carvalho RB; Real Martinez CA
    Arq Bras Cir Dig; 2023; 35():e1702. PubMed ID: 36629684
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genomics and Epigenomics in the Molecular Biology of Melanoma-A Prerequisite for Biomarkers Studies.
    Zob DL; Augustin I; Caba L; Panzaru MC; Popa S; Popa AD; Florea L; Gorduza EV
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614156
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Next-generation Sequencing as a Potential Diagnostic Adjunct in Distinguishing Between Desmoplastic Melanocytic Neoplasms.
    Roth A; Boutko A; Lampley N; Dhillon S; Hagstrom M; Olivares S; Dittman D; Jennings L; Santana Dos Santos L; Busam K; Gerami P
    Am J Surg Pathol; 2023 Mar; 47(3):318-325. PubMed ID: 36383901
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Molecular and immunohistochemical comparison between primary gastrointestinal mucosal melanomas and atypical gastrointestinal stromal tumors.
    Song IH; Sung YE; Kang J; Lee A; Lee SH
    Pathol Res Pract; 2022 Dec; 240():154189. PubMed ID: 36327823
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A cross-sectional study of clinical, dermoscopic, histopathological, and molecular patterns of scalp melanoma in patients with or without androgenetic alopecia.
    Porto AC; Pinto Blumetti T; Calsavara VF; Tardin Torrezan G; Andrade de Paula CA; Lellis R; Pedreira Duprat Neto J; Carraro DM; Casagrande Tavoloni Braga J
    Sci Rep; 2022 Sep; 12(1):15096. PubMed ID: 36064728
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Lisch nodules: an ophthalmic marker of neurofibromatosis type 1].
    Bouirig K; Cherkaoui LO
    Pan Afr Med J; 2022; 42():108. PubMed ID: 36034030
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study.
    Luo L; Shen R; Arora A; Orlow I; Busam KJ; Lezcano C; Lee TK; Hernando E; Gorlov I; Amos C; Ernstoff MS; Seshan VE; Cust AE; Wilmott J; Scolyer RA; Mann G; Nagore E; Funchain P; Ko J; Ngo P; Edmiston SN; Conway K; Googe PB; Ollila D; Lee JE; Fang S; Rees JR; Thompson CL; Gerstenblith M; Bosenberg M; Gould Rothberg B; Osman I; Saenger Y; Reynolds AZ; Schwartz M; Boyce T; Holmen S; Brunsgaard E; Bogner P; Kuan PF; Wiggins C; Thomas NE; Begg CB; Berwick M;
    Pigment Cell Melanoma Res; 2022 Nov; 35(6):605-612. PubMed ID: 35876628
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Diagnostic and follow-up protocol for adult patients with neurofibromatosis type 1 in a Spanish reference unit.
    Solares I; Vinal D; Morales-Conejo M
    Rev Clin Esp (Barc); 2022 Oct; 222(8):486-495. PubMed ID: 35688675
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. diagnosis and treatment of nail melanoma: a review of the clinicopathologic, dermoscopic, and genetic characteristics.
    Darmawan CC; Ohn J; Mun JH; Kim S; Lim Y; Jo SJ; Kim YG; Kim B; Seong MW; Kim BJ; Lee C; Kwak Y; Chung HJ; Virós A; Lee DY
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):651-660. PubMed ID: 35098589
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma.
    Karachaliou GS; Alkallas R; Carroll SB; Caressi C; Zakria D; Patel NM; Trembath DG; Ezzell JA; Pegna GJ; Googe PB; Galeotti JP; Ayvali F; Collichio FA; Lee CB; Ollila DW; Gulley ML; Johnson DB; Kim KB; Watson IR; Moschos SJ
    BMC Cancer; 2022 Jan; 22(1):38. PubMed ID: 34986841
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Challenges in the diagnosis of neurofibromatosis type 1 (nf1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic nf1 gene variants.
    Kehrer-Sawatzki H; Cooper DN
    Hum Genet; 2022 Feb; 141(2):177-191. PubMed ID: 34928431
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.